CTTH OTC
CTT Pharmaceutical Holdings, Inc.
1W: +1.9%
1M: +12.5%
3M: -23.6%
YTD: -9.0%
1Y: -5.0%
3Y: +436.6%
5Y: -27.5%
$0.06
-0.00 (-3.51%)
Weekly Expected Move ±11.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$6K
+0.0% ▲
Operating Income
-$250K
-494.0% ▼
Net Income
-$210K
-397.5% ▼
EPS (Diluted)
$-0.00
-387.5% ▼
EBITDA
-$244K
-583.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $6K | $6K | $6K |
| Gross Profit | $0 | $0 | -$6K | -$6K | -$6K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $584K | $148K | $102K | $36K | $208K |
| Operating Expenses | $584K | $148K | $102K | $36K | $244K |
| Operating Income | -$584K | -$148K | -$109K | -$42K | -$250K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $2K | $121 | $2K |
| Income Before Tax | -$586K | -$133K | -$53K | -$42K | -$210K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$586K | -$133K | -$53K | -$42K | -$210K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$380K | $104K | -$45K | -$36K | -$244K |
| Shares Outstanding | 48M | 50M | 49M | 51M | 52M |